catecholaminergic polymorphic ventricular tachycardia; stress-induced polymorphic ventricular tachycardia
Jump to navigation
Jump to search
Genetics
- autosomal dominant form associated with defects in RYR2 (type1)
- autosomal recessive form associated with defects in CASQ2 (type 2)
- autosomal dominant form associated with defects in CALM1 (type4)
- may be associated with defects in CALM3
Clinical manifestations
- syncope, seizures, or sudden death after physical activity or emotional stress
Diagnostic procedures
Complications
- polymorphic ventricular tachycardia may degenerate into cardiac arrest & cause sudden death
Management
More general terms
References
- ↑ OMIM https://mirror.omim.org/entry/604772
- ↑ OMIM https://mirror.omim.org/entry/611938
- ↑ Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT1) http://www.hfea.gov.uk/8364.html
- ↑ 4.0 4.1 Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015